Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.
2.
4.

The impact of obesity on overall and cancer specific survival in men with prostate cancer.

Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR.

J Urol. 2009 Jul;182(1):112-7; discussion 117. doi: 10.1016/j.juro.2009.02.118. Epub 2009 May 17.

PMID:
19447437
5.

Obesity, interrelated mechanisms, and exposures and kidney cancer.

Moyad MA.

Semin Urol Oncol. 2001 Nov;19(4):270-9. Review.

PMID:
11769879
6.

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1977-83.

7.

Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study.

Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB.

Clin Endocrinol (Oxf). 2006 Jul;65(1):125-31.

PMID:
16817831
8.

Obesity and the risk of prostate cancer (United States).

Bradbury BD, Wilk JB, Kaye JA.

Cancer Causes Control. 2005 Aug;16(6):637-41.

PMID:
16049801
9.
10.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
11.

Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.

Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR.

J Urol. 2005 Mar;173(3):732-6.

PMID:
15711258
12.

Body mass index and risk of prostate cancer in U.S. health professionals.

Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, Willett WC.

J Natl Cancer Inst. 2003 Aug 20;95(16):1240-4.

13.

Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.

Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD.

Asia Pac J Clin Nutr. 2003;12(3):271-6.

14.

Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.

Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML.

Cancer. 2006 Aug 1;107(3):521-9.

15.

Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.

Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):497-502.

16.

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.

Hammarsten J, Högstedt B.

Eur J Cancer. 2005 Dec;41(18):2887-95. Epub 2005 Oct 20.

PMID:
16243513
17.

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.

Breast Cancer Res Treat. 2006 Jun;97(3):245-54. Epub 2005 Dec 6.

PMID:
16331345
18.

Obesity before age 30 years and risk of advanced prostate cancer.

Robinson WR, Stevens J, Gammon MD, John EM.

Am J Epidemiol. 2005 Jun 15;161(12):1107-14.

19.

Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB.

Urology. 2000 Aug 1;56(2):302-6.

PMID:
10925098
20.

Relationship between obesity and prostate cancer.

Amling CL.

Curr Opin Urol. 2005 May;15(3):167-71. Review.

PMID:
15815193
Items per page

Supplemental Content

Write to the Help Desk